IDSA continues to recommend remdesivir for COVID-19, departing from WHO

The Infectious Diseases Society of America said it will continue to recommend remdesivir for patients with severe COVID-19 despite a guideline from WHO last week that recommended against its use in any hospitalized patients. During a teleconference, Rajesh T. Gandhi, MD, a member of the IDSA’s expert panel on COVID-19 treatment and management guidelines and an ID physician at Massachusetts

Read the full article here

Related Articles